Dr Katie Groom
Dr Katie Groom's research focuses on clinical trials of therapies and interventions for the prevention and treatment of the major complications of pregnancy.
Dr Katie Groom is a clinical academic and completed her medical training and PhD studies in the United Kingdom.
She met her kiwi husband and moved to Auckland in 2004 and now has two children. She works as a senior lecturer in the Department of Obstetrics and Gynaecology, University of Auckland and as an obstetrician and maternal fetal medicine subspecialist at National Women’s Health, Auckland City Hospital.
Her research focuses on clinical trials of therapies and interventions for the prevention and treatment of the major complications of pregnancy including preterm birth, fetal growth restriction and preeclampsia.
Dr Groom has led several multicentre randomised controlled trials including the TOCOX trial (rofecoxib for the prevention of preterm delivery), the EPPI trial (enoxaparin for prevention of preeclampsia and intrauterine growth restriction) and the STRIDER NZAus trial (sildenafil for the treatment of severe early onset intrauterine growth restriction).
She is passionate about maximising the impact of clinical trials research and keen to see it integrated into everyday clinical care. Dr Groom is the chairperson of the National Executive Committee for the New Zealand wide ON TRACK Network – Better Health for Mothers and Babies and chairperson of the Interdisciplinary Maternal Perinatal Australasian Collaborative Trials (IMPACT) Network.
A randomised controlled trial of sildenafil therapy to improve the growth of babies in the womb
Dr Katie Groom University of Auckland What is the problem and who…